Bachem Holding AG
BANB
Rankning i aktier
#2516
Bachem Holding AG serves pharmaceutical and biotechnology companies globally,... Bachem Holding AG serves pharmaceutical and biotechnology companies globally, providing products crucial for research, clinical development, and commercial use. The company's primary focus is on the design, manufacturing, and regulatory support for peptide active pharmaceutical ingredients (APIs), specifically targeting novel peptide and oligonucleotide chemical entities (NCEs). Additionally, Bachem offers commercially available NCEs and generic compounds. Its comprehensive service portfolio includes project management, quality assurance and regulatory guidance, analytical testing, production adhering to Good Manufacturing Practices (GMP), manufacturing for research purposes, and expertise in supply chain and vertical integration. Established in 1971, Bachem Holding AG is headquartered in Bubendorf, Switzerland, and functions as a subsidiary of Ingro Finanz AG.
Aktiekurs
$100.60
Marknadsvärde
$7.54B
Förändring (1 dag)
-1.49%
Förändring (1 år)
49.53%
Land
CH
Handel Bachem Holding AG (BANB)
Kategori
Healthcare
Historik för aktiesplit för Bachem Holding AG (BANB)
Aktien Bachem Holding AG (symbol: BANB) har genomgått totalt 2 aktiesplitar.
Den senaste spliten skedde den May 05, 2022.
En BANB-aktie köpt före Jun 29, 2001 motsvarar nu 100 BANB-aktier.
Den senaste spliten skedde den May 05, 2022.
En BANB-aktie köpt före Jun 29, 2001 motsvarar nu 100 BANB-aktier.
Lista över aktiesplitar
| År | Split | Multipel | Kumulativ multipel |
|---|---|---|---|
| 2022-05-05 | 5:1 | x5 | x100 |
| 2001-06-29 | 20:1 | x20 | x20 |
Aktiesplitar för liknande företag eller konkurrenter
| Företag | Antal aktiesplitar | Kumulativ multipel | Land |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
NL
|
|
| 0 | - |
CH
|
